查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599649

伤口生技药品市场：按产品类型、伤口类型、最终用户划分 - 2025-2030 年全球预测

Wound Biologics Market by Product (Biologic Skin Substitutes, Topical Agents), Wound Type (Burns, Surgical and Traumatic Wounds, Ulcers), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年伤口生技药品市场价值为49.8亿美元，预计到2024年将达到54.3亿美元，复合年增长率为9.99%，预计到2030年将达到97亿美元。

伤口生技药品包括生长因子、皮肤替代品和胶原蛋白基质等产品，旨在透过利用生物成分来促进和增强癒合。这些产品可治疗通常对常规治疗有抵抗力的慢性和急性伤口，对于糖尿病患者和老年人等人至关重要。伤口生技药品广泛应用于医院、诊所和居家医疗机构，透过促进早期復健和最大限度地降低感染风险，在改善患者的生活品质方面发挥重要作用。市场动态主要由慢性伤口患者数量的增加、技术进步以及对微创手术的日益偏好所驱动。然而，市场扩张受到高产品成本、严格的监管要求和报销挑战的阻碍。由于医疗保健支出增加和对先进创伤护理解决方案认识的提高，新兴国家尤其具有巨大的成长潜力。该市场还提供了个人化医疗领域的机会，其中生技药品可以根据个别患者的需求进行定制，并强调产品开发的创新。生技公司和研究机构之间的合作和伙伴关係可以进一步推动突破性治疗方法并缩短时间。然而，公司必须克服激烈的竞争和不同的区域监管环境等限制。利用市场机会的策略建议包括投资于具有成本效益的生技药品研究和开发，以及开发包含各种经过充分研究的生技药品的产品系列，以应对不同的伤口类型，其中包括多样化和扩展到开拓的市场。伤口生技药品产业的本质是高度动态的，受到不断创新和不断变化的患者需求的驱动。

主要市场统计
基准年[2023] 49.8亿美元
预测年份 [2024] 54.3亿美元
预测年份 [2030] 97亿美元
复合年增长率（%） 9.99%

市场动态：快速发展的伤口生技药品市场的关键市场洞察

供需的动态交互作用正在改变伤口生技药品市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 政府关于伤口护理的倡议
    • 烧烫伤和交通事故增加
    • 世界老年人口的增加
  • 市场限制因素
    • 伤口护理高成本
  • 市场机会
    • 创新伤口护理生技药品简介
    • 手术中对生物工程皮肤替代品的潜在需求
  • 市场挑战
    • 缺乏训练有素的医生和污染相关的併发症

波特的五力：驾驭伤口生技药品市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解伤口生技药品市场的外部影响

外部宏观环境因素在塑造伤口生技药品市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解伤口生技药品市场的竞争格局

对伤口生技药品市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生技药品市场供应商的绩效评估

FPNV定位矩阵是评估伤口生技药品市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划伤口生技药品市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对伤口生技药品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 政府关于伤口护理的倡议
      • 烧烫伤和交通事故发生率增加
      • 全球人口老化仍在持续
    • 抑制因素
      • 伤口治疗费用高
    • 机会
      • 创新创伤护理生物製剂简介
      • 手术中对生物工程皮肤替代品的潜在需求
    • 任务
      • 缺乏训练有素的医生和污染相关的併发症
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章伤口生技药品市场：副产品

  • 生物皮肤替代品
    • 无细胞动物衍生产品
    • 生物合成产品
    • 人类供体组织衍生产品
  • 外用製剂

第七章依伤口类型分類的伤口生技药品市场

  • 烧伤
  • 手术伤口及外伤伤口
  • 溃疡
    • 糖尿病足溃疡
    • 褥疮
    • 静脉溃疡

第八章伤口生技药品市场：依最终使用者分类

  • 门诊手术中心
  • 烧烫伤中心
  • 医院
  • 伤口诊所

第九章美洲伤口生技药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太伤口生技药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲伤口生技药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Anika Therapeutics, Inc
  • Avita Medical, Inc.
  • B. Braun SE
  • Bioventus Inc.
  • Blaine Labs Inc.
  • ConvaTec Group PLC
  • Cytori Therapeutics Inc.
  • Fibroheal Woundcare Pvt Ltd
  • Integra Lifesciences Holdings Corporation
  • Kerecis hf
  • Marine Polymer Technologies, Inc.
  • MediWound Ltd.
  • Medline Industries, LP
  • Merakris Therapeutics, Inc.
  • MIMEDX GROUP, INC.
  • Molnlycke Health Care AB
  • Nuo Therapeutics, Inc.
  • Organogenesis Inc.
  • Polymedics Innovations GmbH
  • Royal Biologics, Inc.
  • Skye Biologics Holdings, LLC
  • Smith & Nephew PLC
  • Stability Biologics
  • Stryker Corporation
  • Surgilogix, LLC
  • Tides Medical
  • Vericel Corporation
  • Viatris Inc.
  • Vivex Biologics
Product Code: MRR-0315DDADCE4B

The Wound Biologics Market was valued at USD 4.98 billion in 2023, expected to reach USD 5.43 billion in 2024, and is projected to grow at a CAGR of 9.99%, to USD 9.70 billion by 2030.

Wound biologics, encompassing products like growth factors, skin substitutes, and collagen-based matrices, are designed to expedite and enhance healing by leveraging biological components. These products are critical, as they address chronic and acute wounds that are often resistant to traditional treatments, making them essential for populations such as diabetics or the elderly. Widely applied in hospitals, clinics, and home healthcare settings, wound biologics hold a significant role in improving patients' quality of life by promoting faster recovery and minimizing infection risks. The market dynamics are primarily propelled by an increase in chronic wound cases, technological advancements, and the growing preference for minimally invasive procedures. However, market expansion is hampered by high product costs, stringent regulatory requirements, and reimbursement challenges. Notably, emerging economies present significant growth potential due to increasing healthcare expenditure and a rising awareness of advanced wound care solutions. The market also offers opportunities in personalized medicine, where biologics can be tailored to individual patient needs, emphasizing innovation in product development. Collaborations and partnerships between biotechnological firms and research institutions can drive further advancements and reduce time-to-market for breakthrough treatments. Nonetheless, companies need to navigate constraints such as competitive intensity and variable regulatory landscapes across different regions. Strategic recommendations for tapping into market opportunities include investing in R&D for cost-effective biologics, diversifying product portfolios to include a range of well-researched biologics catering to different wound types, and expanding into underpenetrated markets. The nature of the wound biologics industry is highly dynamic, driven by continuous innovation and evolving patient demands, highlighting the necessity for businesses to remain agile and responsive to technological and regulatory changes.

KEY MARKET STATISTICS
Base Year [2023] USD 4.98 billion
Estimated Year [2024] USD 5.43 billion
Forecast Year [2030] USD 9.70 billion
CAGR (%) 9.99%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wound Biologics Market

The Wound Biologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government Initiatives Regarding Wound Care Treatment
    • Rising Incidences of Burn Injuries and Road Accidents
    • Increasing Geriatric Population Globally
  • Market Restraints
    • High Cost of Wound Treatment
  • Market Opportunities
    • Introduction of Innovative Wound Care Biologics
    • Potential Need for Bioengineered Skin Substitutes in Surgeries
  • Market Challenges
    • Lack of Trained Physicians and Complications Associated with the Contamination

Porter's Five Forces: A Strategic Tool for Navigating the Wound Biologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wound Biologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wound Biologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wound Biologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wound Biologics Market

A detailed market share analysis in the Wound Biologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wound Biologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wound Biologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wound Biologics Market

A strategic analysis of the Wound Biologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wound Biologics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Anika Therapeutics, Inc, Avita Medical, Inc., B. Braun SE, Bioventus Inc., Blaine Labs Inc., ConvaTec Group PLC, Cytori Therapeutics Inc., Fibroheal Woundcare Pvt Ltd, Integra Lifesciences Holdings Corporation, Kerecis hf, Marine Polymer Technologies, Inc., MediWound Ltd., Medline Industries, LP, Merakris Therapeutics, Inc., MIMEDX GROUP, INC., Molnlycke Health Care AB, Nuo Therapeutics, Inc., Organogenesis Inc., Polymedics Innovations GmbH, Royal Biologics, Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stability Biologics, Stryker Corporation, Surgilogix, LLC, Tides Medical, Vericel Corporation, Viatris Inc., and Vivex Biologics.

Market Segmentation & Coverage

This research report categorizes the Wound Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products.
  • Based on Wound Type, market is studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government Initiatives Regarding Wound Care Treatment
      • 5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
      • 5.1.1.3. Increasing Geriatric Population Globally
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Wound Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of Innovative Wound Care Biologics
      • 5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wound Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Biologic Skin Substitutes
    • 6.2.1. Acellular Animal-derived Products
    • 6.2.2. Biosynthetic Products
    • 6.2.3. Human Donor Tissue-derived Products
  • 6.3. Topical Agents

7. Wound Biologics Market, by Wound Type

  • 7.1. Introduction
  • 7.2. Burns
  • 7.3. Surgical and Traumatic Wounds
  • 7.4. Ulcers
    • 7.4.1. Diabetic Foot Ulcers
    • 7.4.2. Pressure Ulcers
    • 7.4.3. Venous Ulcers

8. Wound Biologics Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Burn Centers
  • 8.4. Hospitals
  • 8.5. Wound Clinics

9. Americas Wound Biologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wound Biologics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wound Biologics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Anika Therapeutics, Inc
  • 3. Avita Medical, Inc.
  • 4. B. Braun SE
  • 5. Bioventus Inc.
  • 6. Blaine Labs Inc.
  • 7. ConvaTec Group PLC
  • 8. Cytori Therapeutics Inc.
  • 9. Fibroheal Woundcare Pvt Ltd
  • 10. Integra Lifesciences Holdings Corporation
  • 11. Kerecis hf
  • 12. Marine Polymer Technologies, Inc.
  • 13. MediWound Ltd.
  • 14. Medline Industries, LP
  • 15. Merakris Therapeutics, Inc.
  • 16. MIMEDX GROUP, INC.
  • 17. Molnlycke Health Care AB
  • 18. Nuo Therapeutics, Inc.
  • 19. Organogenesis Inc.
  • 20. Polymedics Innovations GmbH
  • 21. Royal Biologics, Inc.
  • 22. Skye Biologics Holdings, LLC
  • 23. Smith & Nephew PLC
  • 24. Stability Biologics
  • 25. Stryker Corporation
  • 26. Surgilogix, LLC
  • 27. Tides Medical
  • 28. Vericel Corporation
  • 29. Viatris Inc.
  • 30. Vivex Biologics

LIST OF FIGURES

  • FIGURE 1. WOUND BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. WOUND BIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WOUND BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WOUND BIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023